T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme PanelMolecular Diagnostic Test for Early Detection of Lyme Disease
T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme PanelMolecular Diagnostic Test for Early Detection of Lyme Disease - read this article along with other careers information, tips and advice on BioSpace
United States John Sperzel Biosystems Inc Us Centers For Disease Drug Administration Exchange Commission
Source: biospace.com